16-fluoroestradiol has been researched along with Carcinoma, Ductal, Breast in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greenspan, D; Lebron, L; Pandit-Taskar, N | 1 |
Apollonio, G; de Vries, EF; Dierckx, RA; Glaudemans, AW; Hospers, GA; Schröder, CP; Venema, CM | 1 |
2 review(s) available for 16-fluoroestradiol and Carcinoma, Ductal, Breast
Article | Year |
---|---|
PET Imaging of Breast Cancer: Role in Patient Management.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Estradiol; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Receptors, Estrogen | 2016 |